Part 4- Treating T3 Deficiency, The Evidence You Need

Part 4- Treating T3 Deficiency, The Evidence You Need

Current Status
Not Enrolled
Price
Free
Get Started

Objectives

Upon completion of this workshop, the healthcare professional will be able to:

  1. Discuss the current recommendations against using T4 monotherapy for SCH due to lack of efficacy in most studies.
  2. Identify why the panel recommended against hormone therapy due to no important benefits of treatment and the possibility of harm.
  3. Review the studies demonstrating a low Free T3 level being responsible for symptomology and CVD.
  4. Review studies demonstrating improvement in symptoms with DTE as well as improvement in Free T3 levels with T3 and DTE, but not T4 monotherapy.
  5. Recall how combination therapy may be controversial but how physicians may prescribe it to improve adherence to treatment and patient well-being.
  6. Define the physiology behind lack of improvement with T4 monotherapy and the appropriate therapy to avoid the lack of efficacy of T4 monotherapy.
  7. Review the multiple studies demonstrating improvement in lipid parameters and a decrease in CIMT with thyroid administration.
  8. Evaluate the recommendations of recent authors and papers that subclinical hypothyroidism should not be treated.  Lack of clinical benefit with thyroxine monotherapy and a lifelong burden of taking a medicine that does not work are discussed.

Instructor

Neal Rouzier, MD

Faculty Chairman

Accreditation

In support of improving patient care, this activity has been planned and implemented by The Foundation for Care Management (FCM) and Worldlink Medical.  FCM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

This program is approved for 1.0 AMA Category 1 Credits.

This program is approved for 1.0 Nursing Contact hour of Education.

Enrollment Options

Enroll today with a Premium Membership for $495/year, for access to THIS course and:

  • All 1 Hour Accredited Courses (28+ more added monthly)
  • All upcoming Accredited Monthly Webinars
  • All upcoming Journal Clubs AND Journal Club Library
  • EBSCOhost – research articles for the BHRT Workshop Series and to support your own evidence based studies!